Key Points
- Delegation Led by State Government: The Cook Labor Government is leading 19 Western Australian (WA) organisations to Queensland for Australia’s Biggest Week in Biotech.
- Key Event Dates: The national trade delegation will participate in the combined AusBiotech and AusMedtech conferences taking place on the Gold Coast from 21 to 23 October, within the broader event week spanning 19 to 23 October.
- Unified Industry Gathering: For the first time, Australia’s Biggest Week in Biotech brings together three major industry forums: the AusBiotech International Conference, the AusMedtech Conference, and AusBiotech Invest.
- Promoting WA Life Sciences: A joint exhibition booth hosted by the Department of Energy and Economic Diversification and the Department of Health will highlight Western Australia’s biomedical, health, and medical technology capabilities.
- Building on Past Success: The initiative builds directly on momentum established when Perth hosted the AusMedtech conference for the first time in May 2026.
- Broad Scope and Attendance: The event is set to feature over 250 expert speakers across 60 sessions, drawing more than 2,000 national and international participants focused on scientific innovation, commercialisation, and investment.
Evening Washington News (EW) October 19, 2026 – The Cook Labor Government is dispatching a delegation of 19 Western Australian businesses and health research organisations to Queensland to showcase the State’s medical technology and biotechnology sectors at Australia’s Biggest Week in Biotech. Operating from 19 to 23 October, the industry gathering brings together major sector conferences to facilitate international commercialisation, investment, and strategic partnerships.
As reported by political and industry correspondents for Evening Washington, the Cook Labor Government has officially spearheaded a major Western Australian trade representation at the Gold Coast Convention and Exhibition Centre. Representing a unified front for Western Australian life sciences, the 19 delegated organisations will take part in the combined AusBiotech and AusMedtech conferences.
To maximize visibility for local innovations, the Department of Energy and Economic Diversification and the Department of Health are hosting a joint state exhibition booth. The state government platform has been structured to connect Western Australian firms directly with potential international buyers, strategic venture capital partners, and leading scientific researchers.
The 2026 gathering marks an industry milestone, as Australia’s Biggest Week in Biotech integrates the AusBiotech International Conference, the AusMedtech Conference, and AusBiotech Invest into a single consolidated program. The gathering is expected to draw over 2,000 registered delegates, featuring more than 250 industry speakers delivering presentations across approximately 60 technical and investment-focused sessions.
This interstate presence builds upon Western Australia’s hosting of AusMedtech in Perth in May 2026. State officials noted that hosting the earlier gathering demonstrated WA’s advanced life science infrastructure and established baseline connections with domestic and international medical technology leaders.
In official media communications released by state representatives, the Cook Labor Government emphasized its strategic focus on economic diversification through health sciences. “This delegation is a great opportunity to showcase our State’s capabilities and strengthen connections with the national and international life sciences community, building off the success of hosting AusMedtech earlier this year,” a government spokesperson stated.
The spokesperson highlighted the commercial objectives of the mission: “By bringing together 19 Western Australian businesses with researchers, investors and industry leaders, Australia’s Biggest Week in Biotech will help open doors to new partnerships, commercial opportunities and investment.”
State leadership further reaffirmed its commitment to local research infrastructure, adding: “The Cook Labor Government is committed to supporting medical research and innovation, helping translate discoveries into real-world applications while growing Western Australia’s health and medical life sciences sector.”
What Is the Significance of Australia’s Biggest Week in Biotech?
As detailed by industry analysts, the 2026 iteration of Australia’s Biggest Week in Biotech marks the first time that AusBiotech, AusMedtech, and AusBiotech Invest have been co-located into a single master event. This consolidation allows companies in early-stage research, clinical development, and medical devices to interface directly with capital allocators without navigating disparate geographical schedules.
The inclusion of more than 60 dedicated sessions across five days allows participating entities to examine regulatory hurdles, global supply chain resilience, clinical trial execution, and international market entry strategies.
How Does Western Australia Plan to Diversify Its Industry Base?
Western Australia’s economy has historically leaned on resource extraction, mining, and primary commodities. The state government’s ongoing support for health and medical life sciences reflects an explicit economic strategy aimed at cultivating high-value knowledge industries.
By sponsoring joint booths and coordinating multi-organisation trade delegations, state departments seek to reduce capital barriers for local small-and-medium enterprises (SMEs) entering global markets. The joint presence of the Department of Energy and Economic Diversification and the Department of Health reflects a multi-agency strategy to bridge scientific research and commercial market integration.
What Role Did the May 2026 AusMedtech Conference in Perth Play?
The foundation for this delegation was established when Perth hosted the AusMedtech conference in May 2026. Serving as the first occasion the medical technology forum was convened in Western Australia, the local ecosystem hosted national delegates, investors, and clinical researchers.
The success of the Perth conference elevated the profile of local research institutes and biotech startups, demonstrating that Western Australia possesses the clinical infrastructure, state-of-the-art diagnostic facilities, and regulatory framework needed to compete on a global scale. The current Gold Coast delegation is designed to maintain that momentum and convert initial contacts into commercial agreements.
Background of Western Australia’s Life Sciences Expansion
The life sciences ecosystem in Western Australia has experienced steady institutional and commercial growth over the past decade. Supported by world-class universities, specialized medical research institutes, and independent clinical trial facilities, the state has built recognized expertise in novel therapeutics, synthetic chemistry, digital diagnostics, and regenerative medicine.
To systematically transition local research into viable export products, the state government launched targeted grant schemes and international trade frameworks. Previous state delegations to national biopharmaceutical conferences have enabled WA entities to secure multi-million dollar co-development deals, access international clinical trial pipelines, and establish manufacturing agreements. The joint involvement of the Department of Health alongside economic development agencies underlines a policy objective: linking public health infrastructure directly with economic growth and global health trade.
